Bioline Rx (BLRX)
Add to Watchlists Create an Alert
1.68
+0.01 +0.60%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
Bioline Rx Shares Outstanding:
22.26M for March 31, 2013Bioline Rx Historical Shares Outstanding Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 22.26M |
| March 5, 2013 | 21.86M |
| Dec. 31, 2012 | 18.37M |
| Sept. 27, 2012 | 17.61M |
| June 30, 2012 | 17.61M |
| Dec. 31, 2011 | 12.36M |
About Shares Outstanding
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares outstanding represents a company's market value spread across the amount of shares outstanding. The amount of shares outstanding is frequently used in ratios such as Earnings Per Share.
Learn More
BLRX Shares Outstanding Benchmarks
| Companies | |
|---|---|
| Array BioPharma | 116.78M |
| Cytokinetics | 148.61M |
| Oramed Pharmaceuticals | 7.223M |
BLRX Shares Outstanding Range, Past 5 Years
| Minimum | 12.36M | Dec 31 2011 |
| Maximum | 22.26M | Mar 31 2013 |
| Average | 18.34M |
BLRX News
BioLineRx (BLRX) Enrolls First Patients in BL-8020 Phase I/II as HCV Treatment
Street Insider Apr 29
Street Insider Apr 29